论文部分内容阅读
我院对21例癌症患者在抗癌化疗时投予奋乃静与大剂量灭吐灵。以此观察其止吐效果。现报道如下。材料与方法21例癌症患者中,男性5例,女性16例、最大年龄65岁、最小20岁、平均43.9岁。均系Ⅱ至Ⅳ期癌症,其中宫颈癌8例,肺癌3例,卵巢癌2例,乳腺癌2例、结肠癌2例,头颈部癌4例。抗癌治疗均采用联合化疗方案,其中用 DDP 方案者15例(每次用 DDP20毫克),采用 CFM 方案者2例(每次用5-F(?)500毫克、丝裂霉素 C8毫克、阿糖胞苷100毫克联合一次推入),4例采用环磷酰胺0.8g 一次静脉推入。以上全部病例为住院病人,化疗前均作过肝肾功能检查。
In our hospital, 21 cases of cancer patients were given perphenazine and large doses of anti-tumor spirit during anti-cancer chemotherapy. In order to observe its antiemetic effect. The report is as follows. Materials and Methods Among the 21 cancer patients, there were 5 males, 16 females, a maximum age of 65 years, a minimum age of 20 years, and an average of 43.9 years. All were stage II to IV cancers, including 8 cases of cervical cancer, 3 cases of lung cancer, 2 cases of ovarian cancer, 2 cases of breast cancer, 2 cases of colon cancer, 4 cases of head and neck cancer. The anti-cancer treatment was performed with a combination chemotherapy regimen in which 15 patients were treated with DDP (20 mg DDP each time) and 2 patients were treated with CFM (5-F (?) 500 mg, mitomycin C 8 mg each). Cytarabine 100 mg was combined with one push), and 4 patients were intravenously injected with cyclophosphamide 0.8 g once. All the above cases were inpatients, and liver and kidney function tests were performed before chemotherapy.